Ironwood IPO priced below expectations-underwriter

NEW YORK Feb 2 (Reuters) - Drug maker Ironwood Pharmaceuticals Inc (IRWD.O) on Tuesday priced shares in its initial public offering below expectations, according to an underwriter.

The Cambridge, Massachusetts-based company said it would sell 16.7 million shares for $11.25 each, raising about $187.5 million.

The company had hoped to sell shares for between $14 and $16 each. (Reporting by Clare Baldwin in New York)